Skip to main content
Equibles

POLYMED · Poly Medicure Limited

Use POLYMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research POLYMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,681.20 INR -11.90 (-0.70%) At close · Nov 13
Rebalance outlook locked
Market Cap
170.41B INR
Shares
101.36M
Volume · Nov 13 30.62K Avg daily vol (3M) 116.93K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,681.20 INR Open1,682.00 INR Day1,658.20–1,690.00 INR 52W close1,191.10–1,967.40 INR Avg vol 30d87K Last earningsNov 5, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 5
Earnings call
Revenue rises 31%, FY27 guidance maintained

Poly Medicure Limited reported half-year consolidated revenue of INR1,106 crores, up 31%, and reiterated FY27 consolidated revenue guidance of INR2,300 crore-INR2,400 crores. It raised standalone EBITDA margin guidance to 26%-27.5%.

3 source passages
Coming on the consolidated picture for the half year, revenue was INR1,106 crores, up 31%. On a consolidated basis, we maintain revenue guidance of INR2,300 crore-INR2,400 crores. We are increasing our standalone EBITDA margin guidance from 25%-27% to 26%-27.5% for FY27 on improved performance. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲24.9% 4.24B INR 852.29M INR '25 Q3 ▲16.6% 4.41B INR 918.34M INR '25 Q4 ▲4.8% 4.03B INR 930.83M INR '26 Q1 ▲5.7% 4.44B INR 918.35M INR '26 Q2 ▲16.4% 4.94B INR 709.30M INR '26 Q3 ▲21.3% 5.35B INR 662.92M INR '26 Q4 ▲30.3% 5.25B INR 860.25M INR '27 Q1 LATEST ▲30.8% 5.81B INR 951.29M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,191.10 INR Now 1,681.20 INR · 63% Range high 1,967.40 INR
vs 200-day avg +9% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:POLYMED +4.3% +6.2% +5.2% +16.0% -5.2%

Exchange listing

Market
XNSE
Ticker
POLYMED
ISIN
INE205C01021
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.polymedicure.com/
Investor relations
https://www.polymedicure.com/financial-results/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-08-28 3.50 INR
2025-09-18 3.50 INR
2024-09-19 3.00 INR
2023-09-21 3.00 INR
2022-09-16 2.50 INR
2021-09-16 2.50 INR
2020-02-27 2.00 INR
2019-09-13 2.00 INR
2018-09-18 2.00 INR
2017-02-15 0.50 INR
2016-11-11 0.50 INR
2016-09-19 0.25 INR
2016-03-17 1.25 INR
2015-09-18 1.25 INR
2014-09-15 1.00 INR
2013-09-19 0.50 INR
2012-09-13 0.375 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-10 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-25 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026